TADFX
Price
$8.50
Change
-$0.24 (-2.75%)
Updated
Dec 18 closing price
VIVIX
Price
$65.90
Change
-$1.70 (-2.51%)
Updated
Dec 18 closing price
Ad is loading...

TADFX vs VIVIX

Header iconTADFX vs VIVIX Comparison
Open Charts TADFX vs VIVIXBanner chart's image
Transamerica Sustainable Equity Inc R6
Price$8.50
Change-$0.24 (-2.75%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$65.90
Change-$1.70 (-2.51%)
VolumeN/A
CapitalizationN/A
TADFX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TADFX vs. VIVIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TADFX is a StrongBuy and VIVIX is a Hold.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. TADFX (174M). VIVIX pays higher dividends than TADFX: VIVIX (2.37) vs TADFX (1.88). TADFX was incepted earlier than VIVIX: TADFX (10 years) vs VIVIX (26 years). TADFX is a more actively managed with annual turnover of: 11.00 vs. VIVIX (10.00). TADFX has a lower initial minimum investment than VIVIX: TADFX (0) vs VIVIX (5000000). TADFX annual gain was more profitable for investors over the last year : 20.69 vs. VIVIX (16.43). VIVIX return over 5 years is better than : 44.60 vs. TADFX (5.06).
TADFXVIVIXTADFX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years26 years-
Gain YTD19.57816.034122%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets174M195B0%
Annual Yield % from dividends1.882.3779%
Returns for 1 year20.6916.43126%
Returns for 3 years-2.9720.48-14%
Returns for 5 years5.0644.6011%
Returns for 10 yearsN/A104.87-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRVI5.800.22
+4.03%
Maravai LifeSciences Holdings
ATLX6.970.01
+0.07%
Atlas Lithium Corp
BHF48.96-0.72
-1.45%
Brighthouse Financial
LII657.59-10.44
-1.56%
Lennox International
ERNA0.26-0.01
-3.61%
Eterna Therapeutics